Galen Joseph, PhD

Title(s)Professor, Humanities & Social Sciences
SchoolSchool of Medicine
Phone415-514-9421
ORCID ORCID Icon0000-0001-9179-7075 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, Santa CruzPhD06/1999Cultural Anthropology
    Wesleyan University, Middletown, CTBA05/1988Anthropology
    Yale University, New Haven, CTPost-Doc06/2001Migration, Globalization, and Citizenship
    UCSF2021Diversity, Equity, and Inclusion Champion Training

    Collapse Overview 
    Collapse Overview
    Dr. Galen Joseph, Ph.D. is a Professor of Anthropology in the Department of Humanities and Social Sciences in the School of Medicine at the University of California, San Francisco. She is also a member of the Helen Diller Family Comprehensive Cancer Center and Affiliate Faculty with the Center for Vulnerable Populations at Zuckerberg San Francisco General Hospital and the Bixby Center for Global Reproductive Health. Her research examines the socio-cultural and institutional dimensions of inequities in cancer care and translational genomics. As an anthropologist, she specializes in ethnographic approaches, and use a range of mixed qualitative and quantitative methods and community engaged research approaches. Her research program has primarily focused on: (1) Genetic Counseling Communication across Language, Literacy, and Culture; (2) Ethical, Legal, Social Issues (ELSI) Research in Clinical Adoption of Genomic Discoveries; and (3) Recruitment of Medically Underserved Populations into Cancer Clinical Trials. A new area of research examines the impact of the Dobbs Supreme Court decision on prenatal genetic counseling and training of genetic counselors in the post-Roe era. This research includes foci on the experience of genetic counselors facing moral distress due to abortion bans and restrictions; changing medical documentation practices to protect patients and providers; and the evolving training of prenatal genetic counseling students in states restricting abortion.

    Key areas of interest include: abortion care post-Roe, genomic medicine, translational medicine, clinical trials recruitment, clinical trials education, health communication and health literacy, cancer, migration, globalization, and identity.
    Collapse Interests

    Collapse Research 
    Collapse Research Activities and Funding
    Prenatal Genetic Counseling and Medical Documentation in the Post-Roe Era
    UCSF REAC Jul 1, 2024 - Jun 30, 2025
    Role: MPI
    Maternal-Fetal Precision Medicine and the Practice of Genetic Counseling in the Post-Dobbs Era
    UCSF Marcus ELSI in Precision Medicine Award Mar 1, 2023 - Jul 1, 2024
    Role: MPI
    Patient and Physician Perspectives on Value, Utility and Implications of Recording Geographic Ancestry from Genomic Sequencing in the Electronic Health Record
    Marcus Program ELSI in Precision Medicine Award Jul 1, 2021 - Dec 31, 2022
    Role: MPI
    Precision Genomics in the WISDOM Pragmatic Clinical Trial: An Embedded ELSI Study of Risk-based Breast Cancer Screening
    NIH R01CA211999Jan 12, 2017 - Dec 31, 2021
    Role: Principal Investigator
    Comparison of 3 Modes of Genetic Counseling in High-Risk Public Hospital Patients
    NIH R01CA197784Apr 12, 2016 - Mar 31, 2021
    Role: Co-Investigator
    Exome sequencing in Diverse Populations in Colorado & Oregon
    NIH U01HG007292Jun 14, 2013 - May 31, 2021
    Role: Co-Investigator
    Engaging Underserved Women in Health Research
    California Breast Cancer Research Program 20BB-2100

    Collapse ORNG Applications 
    Collapse Academic Senate

    Collapse Featured Content 
    Collapse Twitter

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Implementing a genetic testing station in a safety net setting for equitable genetic testing and counseling. Journal of Clinical Oncology. 2024 Sep 30; 20(10_suppl):167-167. Dixit DN, Friedlander FT, Velazquez Manana VA, DeBoer DR, Trejo TE, Leung LI, Frick FM, Tong TB, Gordon GK, Lee LR, Couey CP, Kabra KS, Joseph JG. .
      View in: Publisher Site   Mentions:
    2. Receiving a Pathogenic Variant in a Population Breast Cancer Screening Trial: A Mixed Method Study. Public Health Genomics. 2024; 27(1):177-196. Riddle L, James JE, Naeim A, Madlensky L, Brain S, DeRosa D, Eklund M, Fiscalini AS, Heditsian D, Koenig B, Ross K, Sabacan LP, Tong B, Wenger N, Joseph G. PMID: 39307132.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. “Mammograms are kind of my pacifier”: The cultural context of women’s preference for annual mammograms in a risk-based screening cohort. SSM - Qualitative Research in Health. 2024 Sep 1; 100476. Leggat-Barr LK, Joseph JG, Riddle RL, Caruncho CM, Koenig KB, James JJ. .
      View in: Publisher Site   Mentions:
    4. Evaluation of mailed results versus telephone disclosure of normal cancer genetic test results in a low-risk underserved population. Transl Behav Med. 2024 Jun 27; 14(7):377-385. Gilmore MJ, Leo MC, Amendola LM, Goddard KAB, Ezzell Hunter J, Joseph G, Kauffman TL, Rolf B, Shuster E, Zepp JM, Wilfond BS, Biesecker BB. PMID: 38190737; PMCID: PMC11208290.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Effects of Implicit Racial Bias and Standardized Patient Race on Genetic Counseling Students' Patient-Centered Communication. Health Commun. 2024 Jun 07; 1-12. Lowe C, Beach MC, Erby LH, Biesecker BB, Joseph G, Roter DL. PMID: 38847325.
      View in: PubMed   Mentions:    Fields:    
    6. Improving Care for Marginalized Populations at Risk for Hereditary Cancer Syndromes: Innovations that Expanded Reach in the CHARM Study. Public Health Genomics. 2024; 27(1):16-22. Gilmore MJ, Knerr S, Kraft SA, Bulkley JE, Biesecker BB, Feigelson HS, Hunter JE, Jenkins CL, Kauffman TL, Lee SS, Liles EG, Mittendorf KF, Muessig KR, Porter KM, Rolf BA, Rope AF, Zepp JM, Anderson KP, Devine B, Joseph G, Leo MC, Goddard K, Wilfond BS. PMID: 38142673.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. Promoting equity, inclusion, and efficiency: A team science approach to the development of authorship guidelines for a multi-disciplinary research team. J Clin Transl Sci. 2023; 7(1):e265. Lewis H, Biesecker B, Lee SS, Anderson K, Joseph G, Jenkins CL, Bulkley JE, Leo MC, Goddard KAB, Wilfond BS. PMID: 38229898; PMCID: PMC10790100.
      View in: PubMed   Mentions:
    8. Acceptability of an online communication training intervention for genetic counseling students. J Genet Couns. 2024 Oct; 33(5):952-960. Lowe C, Erby L, Joseph G, Biesecker B, Roter DL. PMID: 37795757.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Refining a Multifaceted Model of Perceived Utility of Genomic Sequencing Results. Public Health Genomics. 2023; 26(1):135-144. Duenas DM, Riddle L, Guerra C, Caruncho M, Lewis H, Porter KM, Kraft SA, Anderson KP, Biesecker B, Gilmore MJ, Zepp JM, Leo MC, Wilfond BS, Joseph G, CHARM Study. PMID: 37607497; PMCID: PMC10614499.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    10. Most people share genetic test results with relatives even if the findings are normal: Family communication in a diverse population. Genet Med. 2023 11; 25(11):100923. Hunter JE, Riddle L, Joseph G, Amendola LM, Gilmore MJ, Zepp JM, Shuster E, Bulkley JE, Muessig KR, Anderson KP, Goddard KAB, Wilfond BS, Leo MC, CHARM study team. PMID: 37421176; PMCID: PMC10766857.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    11. The role of polygenic risk scores in breast cancer risk perception and decision-making. J Community Genet. 2023 Oct; 14(5):489-501. Riddle L, Joseph G, Caruncho M, Koenig BA, James JE. PMID: 37311883; PMCID: PMC10576692.
      View in: PubMed   Mentions: 3  
    12. Efficacy of an online communication skill training intervention on genetic counseling students' performance during standardized patient sessions. Patient Educ Couns. 2023 09; 114:107835. Lowe C, Erby L, Biesecker B, Beach MC, Joseph G, Hundert R, Roter DL. PMID: 37301010; PMCID: PMC11212472.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    13. A Multimethod Evaluation of the Futuros Fuertes Intervention to Promote Healthy Feeding, Screen Time, and Sleep Practices. Acad Pediatr. 2023 Sep-Oct; 23(7):1351-1360. Beck AL, Mora R, Joseph G, Perrin E, Cabana M, Schickedanz A, Fernandez A. PMID: 37211275.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    14. O.30.3 Effects of Online Modules on Genetic Counseling Student Skill Use and Simulated Client Satisfaction Presenter(s): Chenery Lowe, Johns Hopkins Bloomberg School of Public Health, United States. Patient Education and Counseling. 2023 Apr 1; 109:120. Erby EL, Biesecker BB, Joseph JG, Roter RD. .
      View in: Publisher Site   Mentions:
    15. Medical interpreter-mediated genetic counseling for Spanish preferring adults at risk for a hereditary cancer syndrome. J Genet Couns. 2023 08; 32(4):870-886. Joseph G, Lindberg NM, Guerra C, Hernandez C, Karliner LS, Gilmore MJ, Zepp J, Rolf BA, Caruncho M, Riddle L, Kauffman TL, Leo MC, Wilfond BS. PMID: 36938783; PMCID: PMC10509308.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    16. "It's personalized, but it's still bucket based": The promise of personalized medicine vs. the reality of genomic risk stratification in a breast cancer screening trial. New Genet Soc. 2022; 41(3):228-253. James JE, Joseph G. PMID: 36936188; PMCID: PMC10021681.
      View in: PubMed   Mentions: 1  
    17. An accessible, relational, inclusive, and actionable (ARIA) model of genetic counseling compared with usual care: Results of a randomized controlled trial. Genet Med. 2022 11; 24(11):2228-2239. Joseph G, Leo MC, Riddle L, Guerra C, Amendola LM, Gilmore MJ, Rolf BA, Dorschner MO, Zepp J, Biesecker BB, Caruncho M, Hunter JE, Keast E, Lewis HS, Duenas D, Kauffman T, Bulkley JE, Anderson KP, Jarvik GP, Goddard KAB, Wilfond BS, CHARM Study Team. PMID: 36053287.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    18. A qualitative study of unaffected ATM and CHEK2 carriers: How participants make meaning of 'moderate risk' genetic results in a population breast cancer screening trial. J Genet Couns. 2022 12; 31(6):1421-1433. James JE, Riddle L, Caruncho M, Koenig BA, Joseph G. PMID: 35877161; PMCID: PMC9722572.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    19. Literacy-adapted, electronic family history assessment for genetics referral in primary care: patient user insights from qualitative interviews. Hered Cancer Clin Pract. 2022 Jun 10; 20(1):22. Mittendorf KF, Lewis HS, Duenas DM, Eubanks DJ, Gilmore MJ, Goddard KAB, Joseph G, Kauffman TL, Kraft SA, Lindberg NM, Reyes AA, Shuster E, Syngal S, Ukaegbu C, Zepp JM, Wilfond BS, Porter KM. PMID: 35689290; PMCID: PMC9188215.
      View in: PubMed   Mentions: 4  
    20. Implementation of a “genetic testing station” in a safety net hospital to optimize access and increase equity. Journal of Clinical Oncology. 2022 Jun 1; 40(16_suppl):e18565-e18565. Dixit DN, Velazquez Manana VA, Gordon GK, Leung LI, Friedlander FT, Frick FM, Trejo TE, Levine LK, DeBoer DR, Lee LR, Cheng CJ, Couey CP, Wang WC, Joseph JG. .
      View in: Publisher Site   Mentions:
    21. Factors that contribute to disparities in time to acute leukemia diagnosis in young people: an in depth qualitative interview study. BMC Cancer. 2022 May 12; 22(1):531. Ding L, Szymczak JE, Evans E, Canepa E, Martin AE, Contractor F, Aplenc R, Joseph G, Winestone LE. PMID: 35550034; PMCID: PMC9095817.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    22. Laboratory-related outcomes from integrating an accessible delivery model for hereditary cancer risk assessment and genetic testing in populations with barriers to access. Genet Med. 2022 06; 24(6):1196-1205. Amendola LM, Shuster E, Leo MC, Dorschner MO, Rolf BA, Shirts BH, Gilmore MJ, Okuyama S, Zepp JM, Kauffman TL, Mittendorf KF, Bellcross C, Jenkins CL, Joseph G, Riddle L, Syngal S, Ukaegbu C, Goddard KAB, Wilfond BS, Jarvik GP, CHARM Study. PMID: 35305866.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    23. Integration of stakeholder engagement from development to dissemination in genomic medicine research: Approaches and outcomes from the CSER Consortium. Genet Med. 2022 05; 24(5):1108-1119. O'Daniel JM, Ackerman S, Desrosiers LR, Rego S, Knight SJ, Mollison L, Byfield G, Anderson KP, Danila MI, Horowitz CR, Joseph G, Lamoure G, Lindberg NM, McMullen CK, Mittendorf KF, Ramos MA, Robinson M, Sillari C, Madden EB, CSER Stakeholder and Engagement Work Group. PMID: 35227608; PMCID: PMC9081226.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    24. Development and evaluation of an exome sequencing training course for medical interpreters. Per Med. 2022 03; 19(2):125-138. Riddle L, Karliner LS, Livaudais-Toman J, Guerra C, Roat CE, Rope AF, Wade A, Caruncho M, Zepp JM, Giang J, Wilfond BS, Joseph G. PMID: 35171038.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    25. Quality of life of colorectal cancer survivors participating in a pilot randomized controlled trial of physical activity trackers and daily text messages. Support Care Cancer. 2022 May; 30(5):4557-4564. Chan H, Van Loon K, Kenfield SA, Chan JM, Mitchell E, Zhang L, Paciorek A, Joseph G, Laffan A, Atreya C, Fukuoka Y, Miaskowski C, Meyerhardt JA, Venook AP, Van Blarigan EL. PMID: 35119520; PMCID: PMC8942969.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    26. Corrigendum to "Cancer Health Assessments Reaching Many (CHARM): A clinical trial assessing a multimodal cancer genetics services delivery program and its impact on diverse populations" [Contemporary Clinical Trials 106 (2021) 106432]. Contemp Clin Trials. 2022 Mar; 114:106682. Mittendorf KF, Kauffman TL, Amendola LM, Anderson KP, Biesecker BB, Dorschner MO, Duenas DM, Eubanks DJ, Feigelson HS, Gilmore MJ, Hunter JE, Joseph G, Kraft SA, Lee SSJ, Leo MC, Liles EG, Lindberg NM, Muessig KR, Okuyama S, Porter KM, Riddle LS, Rolf BA, Rope AF, Zepp JM, Jarvik GP, Wilfond BS, Goddard KAB, CHARM study team. PMID: 35123916.
      View in: PubMed   Mentions:    Fields:    
    27. Abstract PO-051: Blending research paradigms and methods to compare 3 modes of cancer genetic counseling with diverse public hospital patients: Insights from case studies. Cancer Epidemiology Biomarkers & Prevention. 2022 Jan 1; 31(1_Supplement):po-051-po-051. Pasick PR, Guerra GC, Flores FS, Joseph JG. .
      View in: Publisher Site   Mentions:
    28. Systemic Barriers to Risk-Reducing Interventions for Hereditary Cancer Syndromes: Implications for Health Care Inequities. JCO Precis Oncol. 2021; 5. Mittendorf KF, Knerr S, Kauffman TL, Lindberg NM, Anderson KP, Feigelson HS, Gilmore MJ, Hunter JE, Joseph G, Kraft SA, Zepp JM, Syngal S, Wilfond BS, Goddard KAB. PMID: 34778694; PMCID: PMC8585306.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    29. The limits of personalization in precision medicine: Polygenic risk scores and racial categorization in a precision breast cancer screening trial. PLoS One. 2021; 16(10):e0258571. James JE, Riddle L, Koenig BA, Joseph G. PMID: 34714858; PMCID: PMC8555816.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    30. Research to reduce inequities in cancer risk services: Insights for remote genetic counseling in a pandemic and beyond. J Genet Couns. 2021 10; 30(5):1292-1297. Lee R, Frick M, Joseph G, Guerra C, Stewart S, Kaplan C, Dixit N, Tsoh JY, Flores S, Pasick RJ. PMID: 34687478; PMCID: PMC8657358.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    31. Creating accessible Spanish language materials for Clinical Sequencing Evidence-Generating Research consortium genomic projects: challenges and lessons learned. Per Med. 2021 09; 18(5):441-454. Lindberg NM, Gutierrez AM, Mittendorf KF, Ramos MA, Anguiano B, Angelo F, Joseph G. PMID: 34448595; PMCID: PMC8438935.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    32. Community research collaboration to develop a promotores-based hereditary breast cancer education program for Spanish-speaking Latinas. Health Educ Res. 2021 07 12; 36(3):319-336. Almeida R, Lopez-Macha A, Dugatkin T, Joseph G, Duron Y, Hurtado de Mendoza A, D Graves K, Fejerman L. PMID: 34113985; PMCID: PMC9115327.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    33. Cancer Health Assessments Reaching Many (CHARM): A clinical trial assessing a multimodal cancer genetics services delivery program and its impact on diverse populations. Contemp Clin Trials. 2021 07; 106:106432. Mittendorf KF, Kauffman TL, Amendola LM, Anderson KP, Biesecker BB, Dorschner MO, Duenas DM, Eubanks DJ, Feigelson HS, Gilmore MJ, Hunter JE, Joseph G, Kraft SA, Lee SSJ, Leo MC, Liles EG, Lindberg NM, Muessig KR, Okuyama S, Porter KM, Riddle LS, Rolf BA, Rope AF, Zepp JM, Jarvik GP, Wilfond BS, Goddard KAB, CHARM study team. PMID: 33984519; PMCID: PMC8336568.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    34. eP317 Genomic sequencing results disclosure in diverse and underserved populations: themes, challenges and strategies from the CSER Consortium. Molecular Genetics and Metabolism. 2021 Apr 1; 132:s201-s203. Amendola AL, Suckiel SS, O’Daniel OJ, Donohue DK, Gallagher GK, Gilmore GM, Hendon HL, Joseph JG, Lianoglou LB, Mathews MJ, Norton NM, Ogdis OJ, Poss PA, Rego RS, Scollon SS, Yip YT. .
      View in: Publisher Site   Mentions:
    35. Genomic Sequencing Results Disclosure in Diverse and Medically Underserved Populations: Themes, Challenges, and Strategies from the CSER Consortium. J Pers Med. 2021 Mar 13; 11(3). Suckiel SA, O'Daniel JM, Donohue KE, Gallagher KM, Gilmore MJ, Hendon LG, Joseph G, Lianoglou BR, Mathews JM, Norton ME, Odgis JA, Poss AF, Rego S, Scollon S, Yip T, Amendola LM. PMID: 33805616; PMCID: PMC7998798.
      View in: PubMed   Mentions: 6  
    36. Development and early implementation of an Accessible, Relational, Inclusive and Actionable approach to genetic counseling: The ARIA model. Patient Educ Couns. 2021 05; 104(5):969-978. Riddle L, Amendola LM, Gilmore MJ, Guerra C, Biesecker B, Kauffman TL, Anderson K, Rope AF, Leo MC, Caruncho M, Jarvik GP, Wilfond B, Goddard KAB, Joseph G. PMID: 33549385; PMCID: PMC8881934.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    37. A review and definition of 'usual care' in genetic counseling trials to standardize use in research. J Genet Couns. 2021 02; 30(1):42-50. Biesecker BB, Lillie SE, Amendola LM, Donohue KE, East KM, Foreman AKM, Gilmore MJ, Greve V, Liangolou B, O'Daniel JM, Odgis JA, Rego S, Rolf B, Scollon S, Suckiel SA, Zepp J, Joseph G. PMID: 33278053; PMCID: PMC7882019.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    38. Abstract PO-012: Acceptance and refusal among multi-lingual safety net patients to participate in a trial comparing genetic counseling delivery modes. Cancer Epidemiology Biomarkers & Prevention. 2020 Nov 30; 29(12_Supplement):po-012-po-012. Lee LR, Frick FM, Kaplan KC, Joseph JG, Tsoh TJ, Flores FS, Dixit DN, Cedermaz CH, Wang WL, Khoury KA, Campbell CB, Pasick PR, Guerra GC, Stewart SS. .
      View in: Publisher Site   Mentions:
    39. Abstract PO-050: Reducing disparities in genomic medicine using a literacy-focused genetic counseling model for cancer risk assessment. Cancer Epidemiology Biomarkers & Prevention. 2020 Nov 30; 29(12_Supplement):po-050-po-050. Riddle RL, Amendola AL, Gilmore GM, Rolf RB, Zepp ZJ, Guerra GC, Biesecker BB, Caruncho CM, Anderson AK, Rope RA, Kauffman KT, Lewis LH, Kraft KS, Duenas DD, Wilfond WB, Goddard GK, Joseph JG. .
      View in: Publisher Site   Mentions:
    40. Abstract PO-051: Genetic counseling for high-risk public hospital patients: A randomized and preference-based trial compares delivery in person, by phone, and video. Cancer Epidemiology Biomarkers & Prevention. 2020 Nov 30; 29(12_Supplement):po-051-po-051. Pasick PR, Stewart SS, Lee LR, Guerra GC, Kaplan KC, Joseph JG, Flores FS, Tsoh TJ, Dixit DN, Frick FM, Cedermaz CH, Wong WL, Khoury KA, Campbell CB. .
      View in: Publisher Site   Mentions:
    41. Participant Reactions to a Literacy-Focused, Web-Based Informed Consent Approach for a Genomic Implementation Study. AJOB Empir Bioeth. 2021 Jan-Mar; 12(1):1-11. Kraft SA, Porter KM, Duenas DM, Guerra C, Joseph G, Lee SS, Shipman KJ, Allen J, Eubanks D, Kauffman TL, Lindberg NM, Anderson K, Zepp JM, Gilmore MJ, Mittendorf KF, Shuster E, Muessig KR, Arnold B, Goddard KAB, Wilfond BS. PMID: 32981477; PMCID: PMC7785634.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    42. Abstract PR02: Using web-based tools to assess familial cancer risk in diverse populations. Cancer Epidemiology Biomarkers & Prevention. 2020 Sep 1; 29(9_Supplement):pr02-pr02. Feigelson FH, Mittendorf MK, Kauffman KT, Anderson AK, Okuyama OS, Wilfond WB, Jarvik JG, Amendola AL, McMullen MC, Lynch LF, Eubanks ED, Shuster SE, Allen AJ, Kraft KS, Joseph JG, Lee LS, Goddard GK. .
      View in: Publisher Site   Mentions:
    43. Abstract A034: Extending the reach of genetic counseling to the safety net: Study design and recruitment challenges of a randomized trial. Cancer Epidemiology Biomarkers & Prevention. 2020 Jun 1; 29(6_Supplement_2):a034-a034. Guerra GC, Lee LR, Stewart SS, Kaplan KC, Joseph JG, Tsoh TJ, Dixit DN, Cedermaz CH, Kim KJ, Campbell CJ, Wang WL, Khoury KA, Hellman-Wylie HC, Pasick PR. .
      View in: Publisher Site   Mentions:
    44. Abstract D078: Unlocking the vault: Can 2nd opinions by Comprehensive Cancer Center breast oncologists improve treatment quality for African Americans?. Cancer Epidemiology Biomarkers & Prevention. 2020 Jun 1; 29(6_Supplement_2):d078-d078. Pasick PR, Campbell CB, Rugo RH, Dillard DC, Harris HM, Joseph JG. .
      View in: Publisher Site   Mentions:
    45. Abstract A006: Can expert second opinions reduce treatment disparities for African American breast cancer patients? An exploratory study. Cancer Epidemiology Biomarkers & Prevention. 2020 Jun 1; 29(6_Supplement_1):a006-a006. Campbell CB, Harris HM, Rugo RH, Joseph JG, Pasick PR. .
      View in: Publisher Site   Mentions:
    46. Lessons learned about harmonizing survey measures for the CSER consortium. J Clin Transl Sci. 2020 Apr 24; 4(6):537-546. Goddard KAB, Angelo FAN, Ackerman SL, Berg JS, Biesecker BB, Danila MI, East KM, Hindorff LA, Horowitz CR, Hunter JE, Joseph G, Knight SJ, McGuire A, Muessig KR, Ou J, Outram S, Rahn EJ, Ramos MA, Rini C, Robinson JO, Smith HS, Waltz M, Lee SS. PMID: 33948230; PMCID: PMC8057449.
      View in: PubMed   Mentions: 17  
    47. Integrating stakeholder feedback in translational genomics research: an ethnographic analysis of a study protocol's evolution. Genet Med. 2020 06; 22(6):1094-1101. Kraft SA, McMullen C, Lindberg NM, Bui D, Shipman K, Anderson K, Joseph G, Duenas DM, Porter KM, Kauffman TL, Koomas A, Ransom CL, Jackson P, Goddard KAB, Wilfond BS, Lee SS. PMID: 32089547; PMCID: PMC7275883.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    48. Disparities in Barriers and Facilitators of Acute Leukemia Diagnosis in Young Patients. Blood. 2019 Nov 13; 134(Supplement_1):3415-3415. Ding DL, Martin MA, Canepa CE, Evans EE, Aplenc AR, Szymczak SJ, Joseph JG, Winestone WL. .
      View in: Publisher Site   Mentions:
    49. Self-monitoring and reminder text messages to increase physical activity in colorectal cancer survivors (Smart Pace): a pilot randomized controlled trial. BMC Cancer. 2019 Mar 11; 19(1):218. Van Blarigan EL, Chan H, Van Loon K, Kenfield SA, Chan JM, Mitchell E, Zhang L, Paciorek A, Joseph G, Laffan A, Atreya CE, Fukuoka Y, Miaskowski C, Meyerhardt JA, Venook AP. PMID: 30866859; PMCID: PMC6417122.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    50. Engaging limited English proficient and ethnically diverse low-income women in health research: A randomized trial of a patient navigator intervention. Patient Educ Couns. 2019 07; 102(7):1313-1323. Nickell A, Stewart SL, Burke NJ, Guerra C, Cohen E, Lawlor C, Colen S, Cheng J, Joseph G. PMID: 30772115; PMCID: PMC8846431.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    51. Effective communication in the era of precision medicine: A pilot intervention with low health literacy patients to improve genetic counseling communication. Eur J Med Genet. 2019 May; 62(5):357-367. Joseph G, Lee R, Pasick RJ, Guerra C, Schillinger D, Rubin S. PMID: 30553023; PMCID: PMC7213493.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    52. Genetic Counselor and Healthcare Interpreter Perspectives on the Role of Interpreters in Cancer Genetic Counseling. Health Commun. 2019 11; 34(13):1608-1618. Lara-Otero K, Weil J, Guerra C, Cheng JKY, Youngblom J, Joseph G. PMID: 30230379.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    53. The Clinical Sequencing Evidence-Generating Research Consortium: Integrating Genomic Sequencing in Diverse and Medically Underserved Populations. Am J Hum Genet. 2018 09 06; 103(3):319-327. Amendola LM, Berg JS, Horowitz CR, Angelo F, Bensen JT, Biesecker BB, Biesecker LG, Cooper GM, East K, Filipski K, Fullerton SM, Gelb BD, Goddard KAB, Hailu B, Hart R, Hassmiller-Lich K, Joseph G, Kenny EE, Koenig BA, Knight S, Kwok PY, Lewis KL, McGuire AL, Norton ME, Ou J, Parsons DW, Powell BC, Risch N, Robinson M, Rini C, Scollon S, Slavotinek AM, Veenstra DL, Wasserstein MP, Wilfond BS, Hindorff LA, CSER consortium, Plon SE, Jarvik GP. PMID: 30193136; PMCID: PMC6128306.
      View in: PubMed   Mentions: 87     Fields:    Translation:Humans
    54. Being Present: A single-arm feasibility study of audio-based mindfulness meditation for colorectal cancer patients and caregivers. PLoS One. 2018; 13(7):e0199423. Atreya CE, Kubo A, Borno HT, Rosenthal B, Campanella M, Rettger JP, Joseph G, Allen IE, Venook AP, Altschuler A, Dhruva A. PMID: 30036361; PMCID: PMC6056029.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    55. Effect of physical activity trackers and daily text messages on quality-of-life in colorectal survivors (Smart Pace): A pilot randomized controlled trial. Journal of Clinical Oncology. 2018 Mar 1; 36(7_suppl):168-168. Chan CH, Van Loon VK, Kenfield KS, Chan CJ, Mitchell ME, Zhang ZL, Paciorek PA, Joseph JG, Laffan LA, Fukuoka FY, Miaskowski MC, Meyerhardt MJ, Venook VA, Van Blarigan VE. .
      View in: Publisher Site   Mentions:
    56. Abstract P4-10-05: Engaging linguistically and ethnically diverse low income women in health research: A randomized controlled trial. Poster Session Abstracts. 2018 Feb 15; p4-10-05-p4-10-05. Joseph JG, Nickell NA, Cohen CE, Burke BN, Colen CS, Lawlor LK, Guerra GC, Stewart SS. .
      View in: Publisher Site   Mentions:
    57. Effect of physical activity trackers and daily text messages on quality-of-life in colorectal survivors (Smart Pace): A pilot randomized controlled trial. Journal of Clinical Oncology. 2018 Feb 1; 36(4_suppl):559-559. Chan CH, Van Loon VK, Kenfield KS, Chan CJ, Mitchell ME, Zhang ZL, Paciorek PA, Joseph JG, Laffan LA, Fukuoka FY, Miaskowski MC, Meyerhardt MJ, Venook VA, Van Blarigan VE. .
      View in: Publisher Site   Mentions:
    58. Self-monitoring and reminder text messages to increase physical activity after colorectal cancer (CRC): A pilot randomized controlled trial. Journal of Clinical Oncology. 2018 Feb 1; 36(4_suppl):615-615. Van Blarigan VE, Van Loon VK, Kenfield KS, Chan CJ, Mitchell ME, Chan CH, Zhang ZL, Paciorek PA, Joseph JG, Laffan LA, Fukuoka FY, Miaskowski MC, Meyerhardt MJ, Venook VA. .
      View in: Publisher Site   Mentions:
    59. Cancer genetic counseling communication with low-income Chinese immigrants. J Community Genet. 2018 Jul; 9(3):263-276. Cheng JKY, Guerra C, Pasick RJ, Schillinger D, Luce J, Joseph G. PMID: 29197036; PMCID: PMC6002298.
      View in: PubMed   Mentions: 12  
    60. Erratum to: Information Mismatch: Cancer Risk Counseling with Diverse Underserved Patients. J Genet Couns. 2017 10; 26(5):1105. Joseph G, Pasick RJ, Schillinger D, Luce J, Guerra C, Cheng JKY. PMID: 28432537; PMCID: PMC6827989.
      View in: PubMed   Mentions: 3     Fields:    
    61. Cancer Counseling of Low-Income Limited English Proficient Latina Women Using Medical Interpreters: Implications for Shared Decision-Making. J Genet Couns. 2018 02; 27(1):155-168. Kamara D, Weil J, Youngblom J, Guerra C, Joseph G. PMID: 28791541.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    62. Information Mismatch: Cancer Risk Counseling with Diverse Underserved Patients. J Genet Couns. 2017 Oct; 26(5):1090-1104. Joseph G, Pasick RJ, Schillinger D, Luce J, Guerra C, Cheng JKY. PMID: 28289853; PMCID: PMC5582075.
      View in: PubMed   Mentions: 54     Fields:    Translation:Humans
    63. Effective Cancer Risk Communication to Prevent Disparities in the Era of Precision Medicine. Cancer Epidemiology Biomarkers & Prevention. 2017 Mar 1; 26(3):433-433. Joseph JG, Pasick PR, Schillinger SD, Luce LJ, Cheng CJ, Guerra GC. .
      View in: Publisher Site   Mentions:
    64. Abstract A33: Engaging Linguistically and Ethnically Diverse Low Income Women in Health Research. Behavioral and Social Science. 2017 Feb 1; a33-a33. Nickell NA, Cohen CE, Stewart SS, Cheng CJ, Lawlor LK, Colen CS, Burke BN, Guerra GC, Joseph JG. .
      View in: Publisher Site   Mentions:
    65. Newborn Sequencing in Genomic Medicine and Public Health. Pediatrics. 2017 Feb; 139(2). Berg JS, Agrawal PB, Bailey DB, Beggs AH, Brenner SE, Brower AM, Cakici JA, Ceyhan-Birsoy O, Chan K, Chen F, Currier RJ, Dukhovny D, Green RC, Harris-Wai J, Holm IA, Iglesias B, Joseph G, Kingsmore SF, Koenig BA, Kwok PY, Lantos J, Leeder SJ, Lewis MA, McGuire AL, Milko LV, Mooney SD, Parad RB, Pereira S, Petrikin J, Powell BC, Powell CM, Puck JM, Rehm HL, Risch N, Roche M, Shieh JT, Veeraraghavan N, Watson MS, Willig L, Yu TW, Urv T, Wise AL. PMID: 28096516; PMCID: PMC5260149.
      View in: PubMed   Mentions: 123     Fields:    Translation:HumansPHPublic Health
    66. Survivorship Care Plan Information Needs: Perspectives of Safety-Net Breast Cancer Patients. PLoS One. 2016; 11(12):e0168383. Burke NJ, Napoles TM, Banks PJ, Orenstein FS, Luce JA, Joseph G. PMID: 27992491; PMCID: PMC5161365.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    67. Validation of an Efficient Screening Tool to Identify Low-Income Women at High Risk for Hereditary Breast Cancer. Public Health Genomics. 2016; 19(6):342-351. Stewart SL, Kaplan CP, Lee R, Joseph G, Karliner L, Livaudais-Toman J, Pasick RJ. PMID: 27788513; PMCID: PMC5215008.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    68. Effective Referral of Low-Income Women at Risk for Hereditary Breast and Ovarian Cancer to Genetic Counseling: A Randomized Delayed Intervention Control Trial. Am J Public Health. 2016 Oct; 106(10):1842-8. Pasick RJ, Joseph G, Stewart S, Kaplan C, Lee R, Luce J, Davis S, Marquez T, Nguyen T, Guerra C. PMID: 27552275; PMCID: PMC5024372.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    69. Parental Views on Expanded Newborn Screening Using Whole-Genome Sequencing. Pediatrics. 2016 Jan; 137 Suppl 1:S36-46. Joseph G, Chen F, Harris-Wai J, Puck JM, Young C, Koenig BA. PMID: 26729702; PMCID: PMC4939888.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansPHPublic Health
    70. Educating low-SES and LEP survivors about breast cancer research: pilot test of the Health Research Engagement Intervention. J Cancer Educ. 2014 Dec; 29(4):746-52. Nickell A, Burke NJ, Cohen E, Caprio M, Joseph G. PMID: 24744119; PMCID: PMC4428555.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    71. To worry or not to worry: breast cancer genetic counseling communication with low-income Latina immigrants. J Community Genet. 2015 Jan; 6(1):63-76. Joseph G, Guerra C. PMID: 25148879; PMCID: PMC4286557.
      View in: PubMed   Mentions: 19  
    72. Breast Cancer Gene Research and Medical Practices: Transnational Perspectives in the Time of BRCA. 2014. Sahra Gibbon, Galen Joseph, Jessica Mozersky, Andrea zur Nieden, Sonja Palfner, Editors.
    73. Breast Cancer Gene Research and Medical Practices: Transnational Perspectives in the Time of BRCA. Gibbon S, Joseph G, Mozersky J, zur Nieden A, Palfner S, Editors. Genetics to the People: BRCA as public health and the dissemination of cancer risk knowledge. 2014. Joseph, G. View Publication.
    74. Lynch syndrome patients' views of and preferences for return of results following whole exome sequencing. J Genet Couns. 2014 Aug; 23(4):539-51. Hitch K, Joseph G, Guiltinan J, Kianmahd J, Youngblom J, Blanco A. PMID: 24449059; PMCID: PMC4451087.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    75. Efficient identification of low-income Asian American women at high risk for hepatitis B. J Health Care Poor Underserved. 2013 Nov; 24(4):1701-16. Joseph G, Nguyen K, Nguyen T, Stewart S, Davis S, Kevany S, Marquez T, Pasick R. PMID: 24185165; PMCID: PMC4497776.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    76. Journal of Healthcare for the Poor and Underserved August 2013. Genetic Counseling, Cancer Screening, Breast Cancer Characteristics and General Health among a Diverse Population of BRCA Genetic Testers. 2013; 24(3). Beattie MS, Kopeland C, Fehniger J, Joseph G, Cheung E, Lee R, Luce J. .
    77. Genetic counseling, cancer screening, breast cancer characteristics, and general health among a diverse population of BRCA genetic testers. J Health Care Poor Underserved. 2013 Aug; 24(3):1150-66. Beattie MS, Copeland K, Fehniger J, Cheung E, Joseph G, Lee R, Luce J. PMID: 23974388.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    78. Family communication of BRCA1/2 results and family uptake of BRCA1/2 testing in a diverse population of BRCA1/2 carriers. J Genet Couns. 2013 Oct; 22(5):603-12. Fehniger J, Lin F, Beattie MS, Joseph G, Kaplan C. PMID: 23666114.
      View in: PubMed   Mentions: 56     Fields:    Translation:Humans
    79. Recruitment practices and the politics of inclusion in cancer clinical trials. Med Anthropol Q. 2012 Sep; 26(3):338-60. Joseph G, Dohan D. PMID: 23259347.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    80. Public Health Genomics. Efficient Identification and Referral of Low-Income Women at High Risk for Hereditary Breast Cancer: A Practice-Based Approach. 2012; (15):172-180. Joseph G, Kaplan C, Luce J, Lee R, Stewart S, Guerra C, Pasick R.
    81. P2-13-03: Comparative Assessment of 636 Women at Risk for Hereditary Breast Cancer within 3 Public Hospitals: The Consortium of Underserved BRCA Testers. Poster Session Abstracts. 2011 Dec 15; p2-13-03-p2-13-03. Beattie BM, Ganschow GP, Gabram-Mendola GS, Wilson WA, Joseph JG, Lee LR, Loranger LK, Stanislaw SC, Seelaus SC, Farrell FR, Trim TL, DelPozo DS, Luce LJ. .
      View in: Publisher Site   Mentions:
    82. Abstract A37: Efficient identification of low-income women at high risk for hereditary breast cancer and referral to genetic counseling. Behavioral and Social Science. 2011 Sep 1; a37-a37. Joseph JG, Stewart SS, Lee LR, Kaplan KC, Luce LJ, Marquez MT, Davis DS, Pasick PR. .
      View in: Publisher Site   Mentions:
    83. Abstract A39: The consortium of underserved BRCA testers: A multisite collaboration to study underserved families at risk of hereditary breast and ovarian cancer. Behavioral and Social Science. 2011 Sep 1; a39-a39. Beattie BM, Seelaus SC, Farrell FR, Trim TL, Del Pozo DS, Luce LJ, Ganschow GP, Gabram-Mendola GS, Wilson WA, Fehniger FJ, Joseph JG, Lee LR, Loranger LK, Stanislaw SC. .
      View in: Publisher Site   Mentions:
    84. Special section: Perspectives on globalising genomics: The case of ‘BRCA’ breast cancer research and medical practice. BioSocieties. 2010 Dec 1; 5(4):407-414. Gibbon GS, Joseph JG, Kalender KU, Kampriani KE, Mozersky MJ, Nieden NA, Palfner PS. .
      View in: Publisher Site   Mentions:
    85. Case studies in the co-production of populations and genetics: The making of ‘at risk populations’ in BRCA genetics. BioSocieties. 2010 Dec 1; 5(4):415-439. Mozersky MJ, Joseph JG. .
      View in: Publisher Site   Mentions:
    86. Pre-counseling education for low literacy women at risk of Hereditary Breast and Ovarian Cancer (HBOC): patient experiences using the Cancer Risk Education Intervention Tool (CREdIT). J Genet Couns. 2010 Oct; 19(5):447-62. Joseph G, Beattie MS, Lee R, Braithwaite D, Wilcox C, Metrikin M, Lamvik K, Luce J. PMID: 20490636; PMCID: PMC2944955.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    87. BioSocieties. Perspectives on globalising genomics: The case of ‘BRCA’ breast cancer research and medical practice. 2010; 4(5):407-414. Gibbon S, Joseph G, Kalender U, Kampriani E, Mozersky J, Nieden AZ and Palfner S.
    88. BioSocieties. Case Studies in the Co-Production of Populations and Genetics: the Making of 'At Risk' Populations. 2010; 4(5):415-439. Mozersky J and Joseph G.
    89. Perceived susceptibility to illness and perceived benefits of preventive care: an exploration of behavioral theory constructs in a transcultural context. Health Educ Behav. 2009 Oct; 36(5 Suppl):71S-90S. Joseph G, Burke NJ, Tuason N, Barker JC, Pasick RJ. PMID: 19805792; PMCID: PMC2941192.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansPHPublic Health
    90. Intention, subjective norms, and cancer screening in the context of relational culture. Health Educ Behav. 2009 Oct; 36(5 Suppl):91S-110S. Pasick RJ, Barker JC, Otero-Sabogal R, Burke NJ, Joseph G, Guerra C. PMID: 19805793; PMCID: PMC2921835.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansPHPublic Health
    91. Behavioral theory in a diverse society: like a compass on Mars. Health Educ Behav. 2009 Oct; 36(5 Suppl):11S-35S. Pasick RJ, Burke NJ, Barker JC, Joseph G, Bird JA, Otero-Sabogal R, Tuason N, Stewart SL, Rakowski W, Clark MA, Washington PK, Guerra C. PMID: 19805789; PMCID: PMC2921832.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    92. Theorizing social context: rethinking behavioral theory. Health Educ Behav. 2009 Oct; 36(5 Suppl):55S-70S. Burke NJ, Joseph G, Pasick RJ, Barker JC. PMID: 19805791; PMCID: PMC3548316.
      View in: PubMed   Mentions: 79     Fields:    Translation:Humans
    93. Adult daughters' influence on mothers' health-related decision making: an expansion of the subjective norms construct. Health Educ Behav. 2009 Oct; 36(5 Suppl):129S-44S. Washington PK, Burke NJ, Joseph G, Guerra C, Pasick RJ. PMID: 19805795; PMCID: PMC2945283.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansPHPublic Health
    94. Behavioral Theory and Culture Special Issue: Authors’ Response to Commentaries. Health Education & Behavior. 2009 Oct 1; 36(5_suppl):167s-171s. Pasick PR, Burke BN, Joseph JG. .
      View in: Publisher Site   Mentions:
    95. Recruiting minorities where they receive care: Institutional barriers to cancer clinical trials recruitment in a safety-net hospital. Contemp Clin Trials. 2009 Nov; 30(6):552-9. Joseph G, Dohan D. PMID: 19580887.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    96. Diversity of participants in clinical trials in an academic medical center: the role of the 'Good Study Patient?'. Cancer. 2009 Feb 01; 115(3):608-15. Joseph G, Dohan D. PMID: 19127544.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    97. Development and evaluation of a cancer risk educational tool (CREdIT) for women with a family history of breast and ovarian cancer. Poster Session Abstracts. 2009 Jan 15; 2101. Wilcox WC, Lee LR, Beattie BM, Luce LJ, Joseph JG, Lamvik LK, Crawford CB, Ziegler ZJ, Braithwaite BD. .
      View in: Publisher Site   Mentions:
    98. BRCA testing in underserved women: a qualitative study of intepretations and impacts. Cancer Research. 2009 Jan 15; 69(2_Supplement):3109. Joseph JG, Wilcox WC, Luce LJ, Beattie BM. .
      View in: Publisher Site   Mentions:
    99. Recruiting low-income healthy women to research: an exploratory study. Ethn Health. 2007 Nov; 12(5):497-519. Joseph G, Kaplan CP, Pasick RJ. PMID: 17978946; PMCID: PMC4497777.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    100. Identities: Global Studies in Culture and Power. Taking Race Seriously: Whiteness in Argentina's National and Transnational Imaginary. 2000; 3(7). Joseph G.
    Galen's Networks
    Concepts (200)
    Derived automatically from this person's publications.
    _
    Co-Authors (45)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _